Co-administration of the RSV and shingles adjuvanted vaccines was well tolerated, with acceptable reactogenicity and safety ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of its Herpes Zoster vaccine, Shingrix ...

GSK has abandoned its clinical-stage vaccine for herpes simplex virus (HSV) after a disappointing phase 1/2 trial, ceding the ...

Moreover, GSK's dividend yield of 3.46% as of the latest data, coupled with a history of maintaining dividend payments for 24 consecutive years, underscores the company's commitment to shareholder ...

In 2021, GSK said the factory was likely to close in 2025 when its contract with Sandoz ceased "in the absence of any other ...

It's therefore worth looking at GSK's earnings history below. Of course, the future is what really matters. Investors should note that institutions actually own more than half the company ...

Government’s taxpayer-backed deal for steelworks secures long-term future of south Wales site but unable to secure guarantees to save 2,500 jobs ...

Our Fool likes the look of these stock market juggernauts for the chunky passive income they throw off, not to mention their ...

Advisory committees/consultant: Abbott, Astra-Zeneca, Bayer, Boehringer I, Dexcom, Eli Lilly, GlaxoSmithKline Inc ... but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

This industry-sponsored symposium took place during the European Association of Neurology (EAN) Congress held in Helsinki, Finland, 29 June−2 July, 2024.

GSK has launched it's Shingles vaccine in Malaysia and here's all you need to know about it. From what it is, to the side ...

As of 13 September at 3:39 pm GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.